MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)
$55.88 -0.2 (-0.3566%)
Analysed MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) News Sources
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
27-03-2026
yahoo.com
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
02-03-2026
yahoo.com
Institutional investors in Monopar Therapeutics Inc. (NASDAQ:MNPR) see US$66m decrease in market cap last week, although long-term gains have benefitted them.
11-02-2026
yahoo.com
Broadcom Stock Sees Improved Relative Strength Rating
09-02-2026
yahoo.com
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025
22-12-2025
yahoo.com
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount?
22-11-2025
yahoo.com
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
13-11-2025
yahoo.com
Coinbase upgraded, Six Flags downgraded: Wall Street's top analyst calls
10-11-2025
yahoo.com
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
09-11-2025
yahoo.com
Does Monopar Therapeutics (MNPR) Have the Potential to Rally 42.46% as Wall Street Analysts Expect?
21-10-2025
yahoo.com
What is the current price of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The current price of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is $55.88.
MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) absolute price change since previous trading day?
The absolute price change of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) since the previous trading day is $-0.2.
MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) percentage price change since previous trading day?
The percentage price change of MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) since the previous trading day is -0.3566%.
What is the most recent average sentiment score for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The most recent average sentiment score for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)?
The most recent sentiment for MONOPAR THERAPEUTICS INC (MNPR:NASDAQ) is .
SEC-8K** Filing Available For MONOPAR THERAPEUTICS INC (MNPR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.